Relevant and even prescient commentary on news, politics and the economy.

Dan Shaviro (NYU) and Tim Smeeding (WISC) on NPR’s Detroit Today Show

Dan Shaviro (NYU) and Tim Smeeding (WISC) on NPR’s Detroit Today Show For those of you who may not have the opportunity to tune into Stephen Henderson’s radio program Detroit Today on NPR, it might be useful to have a short summary of the January 9 discussion of the “wealth gap” from that program. Background Tax lawyers […]

Real wages declined slightly in Q4 2019; nearly flat since last January

Real wages declined slightly in Q4 2019; nearly flat since last January In December consumer inflation was +0.2%. Since in last Friday’s jobs report average hourly earnings also increased +0.1%, real average hourly earnings declined slightly: In a longer term perspective, this means that real wages also declined from 97.8% to 97.5% of their all […]

Coming for Your Coverage, Trump’s Plot Against Health Care Continues

Adapted from; “Trump’s Plot Against Health Care Continues, He is still coming for your coverage and lying about it., NYT Opinion, Paul Krugman, January 13, 2019. Trump in a tweet: “Mini Mike Bloomberg is spending a lot of money on False Advertising. I was the person who saved Pre-Existing Conditions in your Healthcare, you have […]

Scenes from the December jobs report: leading jobs sectors and wages

Scenes from the December jobs report: leading jobs sectors and wages Let’s take a more detailed look at last Friday’s December jobs report. First, as usual for the past few months, let’s look at the more leading jobs sectors. This month, let’s also take a more detailed look at wage growth and why it may […]

Scenes from the December jobs report: leading jobs sectors and wages

Scenes from the December jobs report: leading jobs sectors and wages Let’s take a more detailed look at last Friday’s December jobs report. First, as usual for the past few months, let’s look at the more leading jobs sectors. This month, let’s also take a more detailed look at wage growth and why it may […]

Sales Income for Drugs have Exceeded Risk Adjusted R & D Costs

I have been beating the drum for transparency of cost information before granting exclusivity for drugs via patents. With a patent, companies can charge what the market  will bear and have demonstrated they will do so on particular drugs such as insulin, Vimovo, EpiPens, etc. as well as other drugs identified in recent papers on […]